ÜSKÜDAR TEKE, H. Et Al. 2019. Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics. Hematological Diseases and Therapies , vol.1, no.1 , 1-9.

ÜSKÜDAR TEKE, H., ANDIÇ, N., BULDUK, T., GÜNDÜZ, E., BİLGİN, M., AKAY, O. M., ... DURAK ARAS, B.(2019). Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics. Hematological Diseases and Therapies , vol.1, no.1, 1-9.

ÜSKÜDAR TEKE, HAVA Et Al. "Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics," Hematological Diseases and Therapies , vol.1, no.1, 1-9, 2019

ÜSKÜDAR TEKE, HAVA Ü. Et Al. "Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics." Hematological Diseases and Therapies , vol.1, no.1, pp.1-9, 2019

ÜSKÜDAR TEKE, H. Et Al. (2019) . "Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics." Hematological Diseases and Therapies , vol.1, no.1, pp.1-9.

@article{article, author={HAVA ÜSKÜDAR TEKE Et Al. }, title={Which factor is responsible for the prognosis in myelodysplastic syndrome patients with an isolated del(5q) or a cytogenetic abnormality in addition to del(5q): Blast count or cytogenetics}, journal={Hematological Diseases and Therapies}, year=2019, pages={1-9} }